Unichem Laboratories Share Price Today | Stock Price & Unichem Laboratories Share Screener
As of October 5, 2026, the live Unichem Laboratories share price (NSE: UNICHEMLAB) is ₹531.45 on NSE and ₹531.75 on BSE, down 0.67% from the previous close, with shares trading between ₹512.00 and ₹545.00 in today's trading session, and a 52-week range of ₹284.05–₹650.60. Check UNICHEMLAB 52-week chart for the annual price range and momentum. Use the Unichem Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Unichem Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹648 and net income of ₹42, with EBITDA of ₹86, an operating margin of 11.0% and a profit margin of 6.5%.
Unichem Laboratories Share Price Chart
Track the current stock price of Unichem Laboratories with an interactive chart. Analyse UNICHEMLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Unichem Laboratories stock quote in one place.
The quote of ₹531.45 sits between the 52-week low of ₹284.05 and the 52-week high of ₹650.60, and the latest session moved -0.67% from the previous close.
Unichem Laboratories Company Profile - Fundamental Screener
Screen Unichem Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for UNICHEMLAB shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE351A01035.
Company Details
Classification
Identifiers and Leadership
Unichem Laboratories Balance Sheet Screener
Screen UNICHEMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹3,737, up from ₹3,569 in 2025.
Latest statistics put total assets at ₹3,737 and shareholder funds at ₹2,717, with a leverage ratio of 0.19.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 3,737 | 3,569 | 3,275 | 3,193 | 3,319 | 3,126 | 3,145 | 3,150 | 3,194 | 1,527 |
| Current Assets | 2,197 | 2,030 | 1,743 | 1,589 | 1,648 | 1,377 | 1,687 | 2,038 | 2,337 | 749 |
| Fixed Assets | 1,213 | 1,300 | 1,252 | 1,257 | 990 | 884 | 870 | 810 | 578 | 491 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 134 | 127 | 99 | 118 | 148 | 63 | 47 | 27 | 50 | 70 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 2,717 | 2,451 | 2,438 | 2,435 | 2,618 | 2,557 | 2,531 | 2,620 | 2,680 | 1,064 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 18 |
| Reserves & Surplus | 2,703 | 2,437 | 2,424 | 2,421 | 2,604 | 2,543 | 2,517 | 2,606 | 2,666 | 1,045 |
Unichem Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Unichem Laboratories income statement and profit fundamentals. Analyze UNICHEMLAB quarterly results. Unichem Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹648 and net profit was ₹42, equal to earnings per unit of ₹5.89, at an operating margin of 11%.
In that period expenses were ₹563, interest cost ₹7 and tax ₹8. The next period listed, 2026-Mar, shows revenue of ₹599 and net profit of ₹11.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 648 | 599 | 809 | 600 | 533 | 596 | 547 | 516 | 487 | 438 | 545 | 421 | 432 | 407 | 319 |
| Expenses | 563 | 540 | 476 | 571 | 504 | 504 | 448 | 452 | 443 | 532 | 435 | 407 | 395 | 419 | 345 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 86 | 59 | 332 | 29 | 29 | 93 | 99 | 64 | 44 | -94 | 110 | 14 | 37 | -12 | -26 |
| Operating Profit % | 11.00% | 6.00% | 9.00% | 1.00% | 4.00% | 14.00% | 16.00% | 11.00% | 8.00% | -23.00% | 7.00% | 2.00% | 7.00% | -4.00% | -14.00% |
| Depreciation | 30 | 31 | 31 | 32 | 32 | 30 | 31 | 32 | 32 | 27 | 32 | 30 | 29 | 30 | 31 |
| Interest | 7 | 9 | 7 | 8 | 7 | 6 | 7 | 5 | 4 | 5 | 6 | 7 | 6 | 6 | 4 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 49 | 19 | 293 | -11 | -9 | 58 | 62 | 27 | 8 | -126 | 73 | -22 | 2 | -47 | -61 |
| Tax | 8 | 8 | 29 | 1 | 1 | 5 | 4 | 3 | 6 | 3 | 0 | 3 | 3 | -3 | 3 |
| Net Profit | 42 | 11 | 264 | -12 | -11 | 53 | 58 | 25 | 2 | -129 | 73 | -25 | -1 | -44 | -64 |
| EPS | 5.89 | 1.55 | 37.54 | -1.69 | -1.49 | 7.52 | 8.22 | 3.50 | 0.29 | -18.37 | 10.39 | -3.48 | -0.09 | -6.28 | -9.08 |
Unichem Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen UNICHEMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹4, and net cash flow was an inflow of ₹200.
Over the same period, investing activities provided ₹194 and financing activities provided ₹2.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 4 | -7 | 14 | -85 | -260 | 33 | 20 | -328 | -112 | 68 |
| Investing Activities | 194 | -242 | 63 | 241 | 100 | -66 | -36 | -286 | 1,648 | -128 |
Financing and Net Cash | ||||||||||
| Financing Activities | 2 | 184 | -106 | -81 | 191 | -121 | -62 | -2 | -881 | 59 |
| Net Cash Flow | 200 | -65 | -29 | 75 | 32 | -154 | -78 | -616 | 655 | -1 |
Unichem Laboratories Shareholding Pattern Screener
See Unichem Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Unichem Laboratories promoter holding and ownership changes for UNICHEMLAB on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 70.22%, foreign institutions 1.00%, domestic institutions 10.63% and the public 15.22%, spread across 23,386 shareholders.
The shareholder count was 23,386 in 2026-Mar, compared with 25,347 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
Institutional Investors | ||||||||
| FII Holding | 1.00% | 0.90% | 0.98% | 0.98% | 1.00% | 0.99% | 0.90% | 0.89% |
| DII Holding | 10.63% | 10.46% | 11.32% | 10.92% | 10.75% | 10.74% | 11.27% | 11.58% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.22% | 15.59% | 14.80% | 15.16% | 15.26% | 15.18% | 15.12% | 14.80% |
| Other Holding | 2.93% | 2.83% | 2.67% | 2.72% | 2.77% | 2.86% | 2.49% | 2.50% |
| Shareholder Count | 23,386 | 25,347 | 21,621 | 23,010 | 23,577 | 23,267 | 21,171 | 20,621 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Unichem Laboratories. Unichem Laboratories dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹4.00 | 0.81% |
| 2022-March | ₹4.00 | 1.39% |
| 2021-March | ₹4.00 | 1.54% |
| 2020-March | ₹4.00 | 1.29% |
| 2019-March | ₹4.00 | 2.57% |
| 2018-March | ₹5.00 | 2.57% |
| 2017-March | ₹3.00 | 1.05% |
Unichem Laboratories Stock Index Membership - Nifty & Sensex
See which indices include Unichem Laboratories stock. Check UNICHEMLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 3 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Unichem Laboratories Market Events Screener - Corporate Actions
Get Unichem Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Unichem Laboratories stock events that may affect UNICHEMLAB share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 11, 2026, with a record date of August 11, 2026.
It is followed by Annual General Meeting dated August 11, 2026 and Quarterly Result Announcement dated May 22, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | -6.07% |
| 2026-08-11 | 2026-08-11 | Annual General Meeting | NA | 34.15% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | -1.95% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | -1.58% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.98% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | 6.72% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 0.42% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 7.30% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.03% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 9.30% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 8.44% |
| 2022-08-01 | 2022-08-03 | Dividend | ₹ 4.00 /share | 26.80% |
| 2021-07-22 | 2021-07-26 | Dividend | ₹ 4.00 /share | -7.27% |
Unichem Laboratories Competitors Screener - Peer Stocks Comparison
Screen UNICHEMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Unichem Laboratories Company Announcements - News & Reports Screener
Screen UNICHEMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 29, 2026.
The next most recent announcements are dated September 27, 2026 and September 19, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-29 | Announcement Under Regulation 30 (LODR) - USFDA Inspection At Goa Formulation Facility | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-19 | Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-11 | Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018 | - |
| 2026-08-26 | Significant Increase In The Volume Of Securities. | - |
| 2026-08-26 | Clarification sought from Unichem Laboratories Ltd | - |
| 2026-08-12 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-11 | Q1 Financial Statement Of FY 2026-2027 | - |
| 2026-08-11 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-29 | Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-28 | Board Meeting Intimation for To Inter-Alia Consider And Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended 30Th June 2026. | - |
| 2026-07-10 | Response To Clarification Sought On Price Movement | - |
| 2026-07-10 | Clarification sought from Unichem Laboratories Ltd | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-06 | General Announcemnets | - |
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015 | - |
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-03 | Notice Of 63Rd AGM - 11Th August 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹531.45, within a 52-week range of ₹284.05 to ₹650.60. The P/E ratio is 12.62 and the P/B ratio is 1.42, with earnings per unit of ₹35.91. Market capitalisation stands at ₹3,767.06 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.